Cite

HARVARD Citation

    Rush, H. et al. (2022). Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial. Journal of clinical oncology. 40 (8), pp. 825-836. [Online]. 
  
Back to record